By Stephanie Zimmerman, Director of Quality
Across the ACT LAB network, one trend has become impossible to ignore: cannabis flower potency levels are climbing. Over the past several quarters, data from multiple regions and client groups consistently show higher average THC concentrations in tested flower samples.
At first glance, this seems like good news, a sign of improved cultivation practices, advanced genetics, and a maturing market focused on quality. And in many cases, it is. But as our data scientists and analysts have dug deeper, a more complex picture has emerged.
Alongside genuine progress, we’re also seeing signs of potency inflation, the unethical manipulation of samples to artificially boost THC results. This practice threatens the very foundation of consumer trust, regulatory integrity, and fair competition in the legal cannabis market.
Let’s unpack what’s really behind the rise in potency, how honest growers are achieving impressive results, and what ACT LAB is doing to protect the accuracy and credibility of cannabis testing.
Potency Trends Across the ACT LAB Network
ACT LAB’s multi-state data set, covering tens of thousands of flower samples, shows a notable uptick in reported potency levels over the past year. This trend is consistent across several regions and product categories, suggesting a broader industry shift rather than isolated outliers.
Importantly, the majority of these increases appear legitimate. We’re seeing measurable gains in potency from cultivators who have refined their environmental controls, optimized nutrient regimens, and selected higher-yielding phenotypes. Modern cultivation facilities are operating with precision that rivals pharmaceutical production, and it’s paying off in stronger, more cannabinoid-rich flower.
However, not all data tells the same story. A smaller subset of samples displays potency levels that deviate sharply from expected ranges, inconsistent with known strain genetics or historical performance.
How Growers Are Getting It Right
The good news: innovation is working.
Today’s top-tier cultivators are leveraging science and technology to push natural potency boundaries responsibly. Here’s how they’re doing it:
- Advanced Lighting and Environmental Control: LED spectrum tuning and automated climate systems optimize photosynthesis and resin production.
- Genetic Refinement: Focused phenotype selection and tissue culture propagation ensure consistent, high-performing plant lines.
- Enhanced SOPs: Detailed standard operating procedures around harvesting, drying, and curing preserve cannabinoids and terpenes, preventing degradation before testing.
- Optimized Nutrition Strategies: Growers are experimenting with targeted nutrient blends and precisely timed feeding schedules to support peak cannabinoid development.
The result? Naturally stronger, better-balanced flower that delivers superior aroma, flavor, and effects all within the bounds of honest cultivation.
How Testing Itself Contributes to Potency Variability
Even when everyone plays by the rules, potency data can vary for legitimate scientific reasons. Understanding these nuances helps demystify the numbers.
Regulatory Fragmentation
Each state sets its own sampling and testing rules, from who collects samples to how much product must be tested. Some allow producers to select samples; others require third-party collectors. This patchwork of regulations creates inconsistency, which can lead to variability in results and interpretation across state lines.
Meaningful progress comes from advancing consistent, science-based standards. Harmonization initiatives such as the A2LA-NIHC Verify Hemp/Cannabis Recognition Program and AOAC Proficiency Testing exemplify how collaborative, data-driven approaches can improve reliability and comparability across laboratories. ACT LAB actively supports these efforts and integrates third-party best practices to strengthen trust, transparency, and consistency throughout our lab network.
Cannabis Flower Variability
Like any agricultural product, cannabis flower is naturally variable. Just as no two heads of cabbage or ears of corn are identical, individual cannabis buds (even from the same plant) can differ in size, density, and chemical composition. Factors such as light exposure, position on the plant, and curing conditions all influence cannabinoid concentrations.
At ACT LAB, we recognize this natural variability. Our homogeneity testing method samples multiple buds from across a batch to deliver a potency result that reflects the product as a whole, rather than the unique profile of a single bud. Even so, this representative average may still differ slightly from the cannabinoid content found in any single package of flower or pre-roll on the shelf because, like all farm-grown products, each flower has its own natural character.
Lab-to-Lab Variability
Even among compliant labs, minor methodological differences in sample grinding, moisture adjustment, extraction technique, or instrument calibration can lead to measurable variation. That’s why transparency, inter-lab comparison, and consistent data integrity standards are so essential.
Where It Goes Wrong: Potency Inflation
Unfortunately, not every increase in potency comes from science or skill.
A small number of producers have resorted to artificially inflating THC levels by adding kief, hash, or concentrate material to flower samples submitted for testing. The goal is simple: produce a higher THC percentage on the Certificate of Analysis (COA) to attract consumers and command higher prices.
This practice is unethical and misleading to regulators, retailers, and, most importantly, consumers. It distorts market competition by undercutting honest producers and undermines the credibility of legal cannabis as a transparent, regulated industry.
Visually, these manipulated samples often appear normal, making them difficult to detect through inspection alone. It takes careful lab analysis, cross-sample consistency checks, and experience to spot anomalies.
Consumer Impact and Safety Risks
Potency inflation isn’t a victimless offense.
When consumers rely on inflated THC percentages, they may overpay for perceived strength or overconsume products that deliver uneven or unpredictable effects. Over time, this erodes public trust, which is the foundation on which legal cannabis is built.
Moreover, adulterated samples can introduce contamination risks if concentrates or kief are added improperly. What starts as a marketing tactic can become a safety concern.
What ACT LAB Is Doing
As one of the nation’s largest and most trusted cannabis testing networks, ACT LAB takes data integrity seriously. Here’s how we’re protecting the credibility of potency testing across the industry:
- Reinforcing Integrity Checks: We’ve strengthened internal review protocols and implemented cross-lab data comparisons to flag anomalies.
- Enhancing Analytical Methodologies: Our R&D team continually refines extraction and detection methods to ensure data we produce is a true reflection of the sample tested.
- Participating in Method Harmonization: ACT LAB contributes to national inter-lab proficiency studies and method harmonization efforts to promote consistency across the testing landscape.
- Educating Clients and Regulators: We work with producers to explain why results vary and advocate for clearer regulatory standards around sampling and method validation.
Beyond potency, we help clients interpret data holistically by examining moisture content, terpene balance, and homogeneity trends so they can improve consistency over time.
Transparency and Data Integrity: The Only Way Forward
As the cannabis industry evolves, high potency should be a reflection of cultivation excellence, not manipulation. Innovation is raising natural cannabinoid levels, but with that progress comes responsibility.
ACT LAB stands with the producers who play by the rules, and we remain steadfast in our mission to ensure every COA represents scientific truth, not marketing fiction.
By doubling down on transparency, harmonization, and quality-driven testing, we can preserve consumer trust and ensure that rising potency is a story of genuine progress, not inflation.
To learn more about ACT LAB’s commitment to cannabis testing excellence, connect with our team.
